Abstract
BackgroundIn the management of diabetes and high-risk patients, timely treatment with scheduled medicines is critical to prevent severe infections and reduce the risk of lower extremity amputation. However, in Australia, few podiatrists have attained endorsement to prescribe. The aims of this study were to identify the costs associated with developing and implementing a podiatry prescribing mentoring program; and to compare the cost of this program against potential healthcare savings produced.MethodsThis was a cost-description analysis, involving the calculation of costs associated with the development and implementation of a mentoring program to train podiatrists to become endorsed prescribers. Costs were calculated using the Ingredients Method and examined from the perspective of a public health service provider, and the individual learner podiatrist. Breakeven analysis compared the cost of training a podiatry prescriber for endorsement against the potential benefit (savings) made by averting complications of an infected foot ulcer. A sensitivity analysis was conducted to allow for uncertainty in the results of an economic evaluation.ResultsTotal start-up cost for the podiatry prescriber mentoring program was $13, 251. The total cost to train one learner podiatrist was $30, 087, distributed between the hospital $17, 046 and the individual learner $13, 041. In the setting studied, a podiatry prescriber must avert 0.40 major amputations arising from an infected foot ulcer through prescribing to recover the cost of training. If in-kind training costs are included, total cost increases to $50, 654, and the breakeven point shifts to 0.68 major amputations averted.ConclusionThe economic benefits (savings) created by an endorsed prescribing podiatrist over their career in a public health service are likely to outweigh the costs to train a podiatrist to attain endorsement. Further research is required to help understand the effectiveness of podiatry prescribing in reducing diabetic foot related complications and the potential economic impact of podiatry prescribers on this health condition.
Highlights
In the management of diabetes and high-risk patients, timely treatment with scheduled medicines is critical to prevent severe infections and reduce the risk of lower extremity amputation
Podiatrists may obtain endorsement to prescribe through either recognition of substantial exposure in a prescribing area; or through a university qualification with appropriate therapeutic subjects, 100 h of supervision practice and submission of 40 or more log cases demonstrating that the podiatrist has observed the prescription of all classes of drugs available to them
In the management of diabetes and high-risk patients, timely treatment with scheduled medicines is critical to Setting Peninsula Health developed an Endorsed Prescriber Podiatrists (S4 medications) mentoring program funded by the Department of Health and Human Services Victoria Advanced Practice Grant
Summary
In the management of diabetes and high-risk patients, timely treatment with scheduled medicines is critical to prevent severe infections and reduce the risk of lower extremity amputation. Non-medical prescribers have been practicing in Australia for over 10 years These health professionals include nurse practitioners, optometrists, pharmacists and podiatrists [1]. The Australian Health Practitioner Regulation Agency (AHPRA) regulates each of these professions endorsed to prescribe [2] All of these non-medical prescribers have a Within Australia, national legislation allows endorsed podiatry prescribers to prescribe and/or dispense to a limited amount of Schedule 2, 3, 4 and 8 medications [4]. Hindered access to medical specialists can result in significant delays before these therapies can commence These delays can result in increased severity of the presenting complaint or development of secondary complications. This is an area that a podiatrist may be best positioned to act and utilise their prescribing skills
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
